查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654378

敗血症診斷市場規模、佔有率、趨勢分析報告：按產品、技術、病原體、測試、方法、最終用途、地區、細分預測，2025-2030 年

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

敗血症診斷市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球敗血症診斷市場規模預計到2030年將達到18.2億美元，2025年至2030年期間的複合年成長率為8.09%。

在預計預測期內，敗血症的高盛行率、技術先進的診斷系統的採用以及政府舉措的增加將推動市場成長。敗血症是一種因對血液中存在的致病微生物產生反應而發生的血液疾病。患有這種疾病的患者會遭受嚴重的發炎和長期住院的困擾。

根據世界衛生組織估計，每年約有3000萬人患有這種疾病。根據 NCBI 介紹，該疾病在年輕人和老年人中最為常見。因此，對該疾病的早期診斷的需求日益增加。根據世界衛生組織報告，全球每年有120萬名嬰兒和300萬名新生兒感染此病。這進一步增加了對提供更快結果和改善患者治療效果的診斷工具的需求。在預計預測期內，敗血症監管部門的核准不斷增加以及技術先進的診斷解決方案的採用將推動市場成長。

2018年5月，美國新興診斷解決方案公司T2 Biosystems, Inc.獲得美國FDA核准，其T2細菌檢測板可用於檢測人體全血檢體中特定的導致敗血症的細菌病原體。 COVID-19 疫情對敗血症診斷的成長產生了中等程度的正面影響。冠狀病毒的全球傳播和 COVID-19 患者中膿毒症的發生可能會擴大人們對快速檢測的興趣，並加速使用用於膿毒症識別的儀器、試劑和檢測試劑套件。由於疫情而實施的封鎖和其他限制措施導致人們的健康檢查延遲，影響了檢測數量和試劑交易。

這種流行病使更容易出現併發症的老年人處於危險之中，增加了罹患敗血症（一種以肺炎為特徵的嚴重呼吸窘迫疾病）的風險。這使得早期發現 COVID-19 患者敗血症成為必要。全球敗血症聯盟估計，大約 2.0-5.0% 的 COVID-19 患者在住院 8-10 天後會出現敗血症症狀，包括多重器官功能障礙。為了應對這種情況，生物醫學高級研究與發展局於 2020 年 5 月擴大了與貝克曼庫爾特公司的合作，開發了一種檢測 COVID-19 患者敗血症的數位演算法。

敗血症診斷市場報告重點

  • 按產品分類，血液培養基在 2024 年佔據市場主導地位，收益佔有率超過 38.90%。
  • 2024 年，微生物技術部門在全球市場佔據主導地位，佔總收益的最大佔有率，超過 48.77%。
  • 細菌部門在 2024 年佔據了 86.22% 的最大收益佔有率，並且預計在預測期內仍將保持領先地位，這歸因於細菌性敗血症病例的增加、醫院內感染發病率的增加以及外科手術數量的增加。
  • 在 2024 年的敗血症診斷產業中，傳統診斷部分佔最大的收入佔有率，為 57.12%。
  • 由於住院人數增加，醫院和診所部門在 2024 年佔據了 79.42% 的最大收益佔有率。
  • 就 2024 年的收益佔有率而言，實驗室測試部門佔據市場主導地位。實驗室檢測的進步使得敗血症檢測變得更容易、更快捷，進而改善了患者的治療效果。
  • 2024 年北美在全球敗血症診斷市場佔據主導地位，佔據最大的收益佔有率，超過 43.9%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 敗血症診斷市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素分析
    • 產業挑戰
  • 敗血症診斷：市場分析工具
    • 波特的分析
    • 敗血症診斷—宏觀經濟分析

4. 敗血症診斷市場：細分分析、按產品，2018-2030 年

  • 敗血症診斷市場：產品變異分析
  • 按產品

5. 敗血症診斷市場：細分分析、依技術分類，2018-2030 年

  • 敗血症診斷市場：技術變革分析
  • 依技術分類

6. 敗血症診斷市場：細分分析、病原體、2018-2030 年

  • 敗血症診斷市場：病原體變異分析
  • 依病原體

7. 敗血症診斷市場：細分分析、按測試，2018-2030 年

  • 敗血症診斷市場：測試變異分析
  • 通過測試

8. 敗血症診斷市場：細分分析、方法論，2018-2030 年

  • 敗血症診斷市場：方法變異分析
  • 依方法

9. 敗血症診斷市場：細分分析、依最終用途，2018-2030 年

  • 敗血症診斷市場：最終用途變異分析
  • 按最終用途

第 10 章敗血症診斷市場：區域估計和趨勢分析、按產品、按技術、按病原體、按測試、按方法、按最終用途

  • 敗血症診斷市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章 競爭格局

  • 公司分類
  • 公司市場定位
    • 市場領導者
  • 公司簡介
    • Biomerieux Sa
    • Becton, Dickinson And Company（Bd）
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche
    • Luminex Corporation
    • Danaher
    • Luminex Corporation
    • Bruker Corporation
    • Amara Health Analytics
    • Cepheid
    • Beckman Coulter, Inc.
    • Bruker Corporation
    • Immunexpress, Inc.
    • Koninklijke Philips NV
Product Code: GVR-1-68038-352-2

Sepsis Diagnostics Market Growth & Trends:

The global sepsis diagnostics market size is expected to reach USD 1.82 billion by 2030, registering a CAGR of 8.09% from 2025 to 2030, according to a new report by Grand View Research, Inc. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization.

According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period.

In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going to expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.

The pandemic has featured the risk upon elders, who are more defenseless to complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.

Sepsis Diagnostics Market Report Highlights:

  • Based on product, blood culture media dominated the market in 2024 with a revenue share of more than 38.90%, as blood culture is considered to be the most cost-effective and convenient mode of testing.
  • The microbiology technology segment dominated the global market in 2024 and accounted for the largest share of more than 48.77% of the overall revenue.
  • Bacterial segment held the largest revenue share of 86.22% in 2024 and is anticipated to maintain its lead over the forecast period owing to the rise in cases of bacterial sepsis, higher occurrence of hospital-transmitted infections, and rising number of surgical procedures conducted.
  • The conventional diagnostics segment held the largest revenue share of 57.12% of the sepsis diagnostics industry in 2024.
  • The hospital and clinics segment held the largest revenue share of 79.42% in 2024, owing to an increase in hospitalization.
  • The laboratory testing segment dominated the market in 2024 in terms of revenue share. Advancements in laboratory testing have made it easier and faster to detect sepsis, leading to better outcomes for patients.
  • North America sepsis diagnostics market dominated globally in 2024 and accounted for the largest revenue share of more than 43.9%.

Table Of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
  • 1.2 Market Definitions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database:
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach: Commodity Flow Approach
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.4 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product And Technology Snapshot
  • 2.3 Pathogen And Testing Snapshot
  • 2.4 Method And End Use Snapshot
  • 2.5 Competitive Landscape Snapshot

Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increase In Prevalence Of Sepsis
      • 3.2.1.2 Rise In Incidence Of Hospital-Acquired Infections
      • 3.2.1.3 Increase In The Number Of Pneumonia Cases
      • 3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Automated Diagnostic Instruments
      • 3.2.2.2 Lack Of Awareness About Sepsis
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
  • 3.3 Sepsis Diagnostics: Market Analysis Tools
    • 3.3.1 Porter's Analysis
    • 3.3.2 Sepsis Diagnostics - Macroeconomic Analysis

Chapter 4 Sepsis Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Sepsis Diagnostics Market: Product Movement Analysis
  • 4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
    • 4.2.1 Instrument
    • 4.2.2 Blood Culture Media
    • 4.2.3 Assay Kits And Reagents
    • 4.2.4 Software

Chapter 5 Sepsis Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Sepsis Diagnostics Market: Technology Movement Analysis
  • 5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
    • 5.2.1 Microbiology
    • 5.2.2 Molecular Diagnostics
      • 5.2.2.1 Polymerase Chain Reaction (Pcr)
      • 5.2.2.2 Dna Microarrays
      • 5.2.2.3 Syndromic Panel Testing
      • 5.2.2.4 Others
    • 5.2.3 Immunoassays
    • 5.2.4 Flow Cytometry
    • 5.2.5 Others

Chapter 6 Sepsis Diagnostics Market: Segment Analysis, By Pathogen, 2018 - 2030 (USD Million)

  • 6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
  • 6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
    • 6.2.1 Bacterial Sepsis
      • 6.2.1.1 Gram-Positive Bacteria
      • 6.2.1.2 Gram-Negative Bacteria
    • 6.2.2 Fungal Sepsis
    • 6.2.3 Viral Sepsis
    • 6.2.4 Others

Chapter 7 Sepsis Diagnostics Market: Segment Analysis, By Testing, 2018 - 2030 (USD Million)

  • 7.1 Sepsis Diagnostics Market: Testing Movement Analysis
  • 7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing (USD Million)
    • 7.2.1 Laboratory Testing
    • 7.2.2 Point-Of-Care Testing

Chapter 8 Sepsis Diagnostics Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)

  • 8.1 Sepsis Diagnostics Market: Method Movement Analysis
  • 8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
    • 8.2.1 Automated Diagnostics
    • 8.2.2 Conventional Diagnostics

Chapter 9 Sepsis Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 9.1 Sepsis Diagnostics Market: End Use Movement Analysis
  • 9.2 Sepsis Diagnostics Market Estimates & Forecast, By End Use (USD Million)
    • 9.2.1 Hospitals & Clinics
    • 9.2.2 Pathology & Reference Laboratories
    • 9.2.3 Research Institutes And Others

Chapter 10 Sepsis Diagnostic Market: Regional Estimates And Trend Analysis, By Product, By Technology, By Pathogen, By Testing, By Method, & By End Use

  • 10.1 Sepsis Diagnostic Market: Regional Outlook
  • 10.2 North America
    • 10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.1.1 Regulatory Framework
      • 10.2.1.2 Reimbursement Scenario
    • 10.2.2 U.S.
      • 10.2.2.1 Key Country Dynamics
      • 10.2.2.2 U.S. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.2.3 Market & Competitive Scenario
    • 10.2.3 Canada
      • 10.2.3.1 Key Country Dynamics
      • 10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.3.3 Market And Competitive Scenario
  • 10.3 Europe
    • 10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.1.1 Regulatory Framework
      • 10.3.1.2 Reimbursement Scenario
    • 10.3.2 Uk
      • 10.3.2.1 Key Country Dynamics
      • 10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.2.3 Market & Competitive Scenario
    • 10.3.3 Germany
      • 10.3.3.1 Key Country Dynamics
      • 10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.3.3 Market & Competitive Scenario
    • 10.3.4 France
      • 10.3.4.1 Key Country Dynamics
      • 10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.4.3 Market & Competitive Scenario
    • 10.3.5 Spain
      • 10.3.5.1 Key Country Dynamics
      • 10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.5.3 Market & Competitive Scenario
    • 10.3.6 Italy
      • 10.3.6.1 Key Country Dynamics
      • 10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.6.3 Market & Competitive Scenario
    • 10.3.7 Denmark
      • 10.3.7.1 Key Country Dynamics
      • 10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.7.3 Market & Competitive Scenario
    • 10.3.8 Sweden
      • 10.3.8.1 Key Country Dynamics
      • 10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.8.3 Market & Competitive Scenario
    • 10.3.9 Norway
      • 10.3.9.1 Key Country Dynamics
      • 10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.9.3 Market & Competitive Scenario
    • 10.3.10 Russia
      • 10.3.10.1 Key Country Dynamics
      • 10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.10.3 Market & Competitive Scenario
      • 10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.1.1 Regulatory Framework
      • 10.4.1.2 Reimbursement Scenario
    • 10.4.2 Japan
      • 10.4.2.1 Key Country Dynamics
      • 10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.2.3 Market And Competitive Scenario
    • 10.4.3 China
      • 10.4.3.1 Key Country Dynamics
      • 10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.3.3 Market And Competitive Scenario
    • 10.4.4 India
      • 10.4.4.1 Key Country Dynamics
      • 10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.4.3 Market And Competitive Scenario
    • 10.4.5 Australia
      • 10.4.5.1 Key Country Dynamics
      • 10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.5.3 Market And Competitive Scenario
    • 10.4.6 Thailand
      • 10.4.6.1 Key Country Dynamics
      • 10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.6.3 Market And Competitive Scenario
    • 10.4.7 South Korea
      • 10.4.7.1 Key Country Dynamics
      • 10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.7.3 Market And Competitive Scenario
    • 10.4.8 Singapore
      • 10.4.8.1 Key Country Dynamics
      • 10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.8.3 Market And Competitive Scenario
      • 10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.1.1 Regulatory Framework
      • 10.5.1.2 Reimbursement Scenario
    • 10.5.2 Brazil
      • 10.5.2.1 Key Country Dynamics
      • 10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.2.3 Market And Competitive Scenario
    • 10.5.3 Mexico
      • 10.5.3.1 Key Country Dynamics
      • 10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.3.3 Market And Competitive Scenario
    • 10.5.4 Argentina
      • 10.5.4.1 Key Country Dynamics
      • 10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.4.3 Market And Competitive Scenario
      • 10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6 MEA
    • 10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.1.1 Regulatory Framework
      • 10.6.1.2 Reimbursement Scenario
    • 10.6.2 South Africa
      • 10.6.2.1 Key Country Dynamics
      • 10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.2.3 Market And Competitive Scenario
    • 10.6.3 Saudi Arabia
      • 10.6.3.1 Key Country Dynamics
      • 10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.3.3 Market And Competitive Scenario
    • 10.6.4 UAE
      • 10.6.4.1 Key Country Dynamics
      • 10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.4.3 Competitive Scenario
    • 10.6.5 Kuwait
      • 10.6.5.1 Key Country Dynamics
      • 10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.5.3 Market And Competitive Scenario
      • 10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 Company Categorization
  • 11.2 Company Market Positioning
    • 11.2.1 Market Leaders
      • 11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2024
  • 11.4 Company Profiles
  • 11.4 Company Profiles
    • 11.4.1 Biomerieux Sa
      • 11.4.1.1 Company Overview
      • 11.4.1.2 Financial Performance
      • 11.4.1.3 Product Benchmarking
      • 11.4.1.4 Strategic Initiatives
    • 11.4.2 Becton, Dickinson And Company (Bd)
      • 11.4.2.1 Company Overview
      • 11.4.2.2 Financial Performance
      • 11.4.2.3 Product Benchmarking
      • 11.4.2.4 Strategic Initiatives
    • 11.4.3 Thermo Fisher Scientific, Inc.
      • 11.4.3.1 Company Overview
      • 11.4.3.2 Financial Performance
      • 11.4.3.3 Product Benchmarking
      • 11.4.3.4 Strategic Initiatives
    • 11.4.4 F. Hoffmann-La Roche
      • 11.4.4.1 Company Overview
      • 11.4.4.2 Financial Performance
      • 11.4.4.3 Product Benchmarking
      • 11.4.4.4 Strategic Initiatives
    • 11.4.5 Luminex Corporation
      • 11.4.5.1 Company Overview
      • 11.4.5.2 Financial Performance
      • 11.4.5.3 Product Benchmarking
      • 11.4.5.4 Strategic Initiatives
    • 11.4.6 Danaher
      • 11.4.6.1 Cepheid
        • 11.4.6.1.1 Company Overview
        • 11.4.6.1.2 Financial Performance
        • 11.4.6.1.3 Product Benchmarking
        • 11.4.6.1.4 Strategic Initiatives
      • 11.4.6.2 Beckman Coulter, Inc.
        • 11.4.6.2.1 Company Overview
        • 11.4.6.2.2 Financial Performance
        • 11.4.6.2.3 Product Benchmarking
        • 11.4.6.2.4 Strategic Initiatives
    • 11.4.7 Luminex Corporation
      • 11.4.7.1 Company Overview
      • 11.4.7.2 Financial Performance
      • 11.4.7.3 Product Benchmarking
      • 11.4.7.4 Strategic Initiatives
    • 11.4.8 Bruker Corporation
      • 11.4.8.1 Company Overview
      • 11.4.8.2 Financial Performance
      • 11.4.8.3 Product Benchmarking
      • 11.4.8.4 Strategic Initiatives
    • 11.4.9 Amara Health Analytics
      • 11.4.9.1 Company Overview
      • 11.4.9.2 Financial Performance
      • 11.4.9.3 Product Benchmarking
      • 11.4.9.4 Strategic Initiatives
    • 11.4.10 Cepheid
      • 11.4.10.1 Company Overview
      • 11.4.10.2 Financial Performance
      • 11.4.10.3 Product Benchmarking
      • 11.4.10.4 Strategic Initiatives
    • 11.4.11 Beckman Coulter, Inc.
      • 11.4.11.1 Company Overview
      • 11.4.11.2 Financial Performance
      • 11.4.11.4 Product Benchmarking
      • 11.4.11.4 Strategic Initiatives
    • 11.4.12 Bruker Corporation
      • 11.4.12.1 Company Overview
      • 11.4.12.2 Financial Performance
      • 11.4.12.3 Product Benchmarking
      • 11.4.12.4 Strategic Initiatives
    • 11.4.13 Immunexpress, Inc.
      • 11.4.13.1 Company Overview
      • 11.4.13.2 Financial Performance
      • 11.4.13.3 Product Benchmarking
      • 11.4.13.4 Strategic Initiatives
    • 11.4.14 Koninklijke Philips N.V.
      • 11.4.14.1 Company Overview
      • 11.4.14.2 Financial Performance
      • 11.4.14.3 Product Benchmarking
      • 11.4.14.4 Strategic Initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 4 North America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 5 North America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 7 North America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 8 North America sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 9 North America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 10 North America sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 14 U.S. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 15 U.S. sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 16 U.S. sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 17 U.S. sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 18 Canada sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 21 Canada sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 22 Canada sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 23 Canada sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 24 Canada sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 25 Europe sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 28 Europe sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 29 Europe sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 30 Europe sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 31 Europe sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 32 Europe sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 33 Germany sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 36 Germany sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 37 Germany sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 38 Germany sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 39 Germany sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41 UK sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 UK sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 43 UK sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 44 UK sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 45 UK sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 46 UK sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 47 France sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 France sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 49 France sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 50 France sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 51 France sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 52 France sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 53 France sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 54 Italy sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 55 Italy sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 56 Italy sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 57 Italy sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 58 Italy sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 59 Italy sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 60 Italy sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 61 Spain sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62 Spain sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 63 Spain sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 64 Spain sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 65 Spain sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 66 Spain sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 67 Spain sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 68 Russia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 69 Russia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 70 Russia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 71 Russia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 72 Russia sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 73 Russia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 74 Russia sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 75 Denmark sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 Denmark sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 77 Denmark sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 78 Denmark sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 79 Denmark sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 80 Denmark sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 81 Denmark sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 82 Sweden sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 83 Sweden sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 84 Sweden sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 85 Sweden sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 86 Sweden sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 87 Sweden sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 88 Sweden sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 89 Norway sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 90 Norway sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 91 Norway sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 92 Norway sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 93 Norway sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 94 Norway sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 95 Norway sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 104 China sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 105 China sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 106 China sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 107 China sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 108 China sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 109 China sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 110 China sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 111 India sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 112 India sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 113 India sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 114 India sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 115 India sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 116 India sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 117 India sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 118 Australia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 119 Australia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 120 Australia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 121 Australia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 122 Australia sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 123 Australia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 124 Australia sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 125 Japan sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 126 Japan sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 127 Japan sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 128 Japan sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 129 Japan sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 130 Japan sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 131 Japan sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 132 South Korea sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 133 South Korea sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 134 South Korea sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 135 South Korea sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 136 South Korea sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 137 South Korea sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 138 South Korea sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 139 Singapore sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 140 Singapore sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 141 Singapore sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 142 Singapore sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 143 Singapore sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 144 Singapore sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 145 Singapore sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 146 Thailand sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 147 Thailand sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 148 Thailand sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 149 Thailand sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 150 Thailand sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 151 Thailand sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 152 Thailand sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 153 Latin America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 154 Latin America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 155 Latin America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 156 Latin America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 157 Latin America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 158 Latin America sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 159 Latin America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 160 Latin America sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 161 Brazil sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 162 Brazil sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 163 Brazil sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 164 Brazil sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 165 Brazil sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 166 Brazil sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 167 Brazil sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 168 Mexico sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 169 Mexico sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 170 Mexico sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 171 Mexico sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 172 Mexico sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 173 Mexico sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 174 Mexico sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 175 Argentina sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 176 Argentina sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 177 Argentina sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 178 Argentina sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 179 Argentina sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 180 Argentina sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 181 Argentina sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 182 MEA sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 183 MEA sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 184 MEA sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 185 MEA sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 186 MEA sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 187 MEA sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 188 MEA sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 189 MEA sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 190 South Africa sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 191 South Africa sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 192 South Africa sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 193 South Africa sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 194 South Africa sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 195 South Africa sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 196 South Africa sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 197 Saudi Arabia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 198 Saudi Arabia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 199 Saudi Arabia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 200 Saudi Arabia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 201 Saudi Arabia sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 202 Saudi Arabia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 203 Saudi Arabia sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 204 UAE sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 205 UAE sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 206 UAE sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 207 UAE sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 208 UAE sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 209 UAE sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 210 UAE sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 211 Kuwait sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 212 Kuwait sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 213 Kuwait sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 214 Kuwait sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 215 Kuwait sepsis diagnostics market estimates and forecasts, by testing, 2018 - 2030 (USD Million)
  • Table 216 Kuwait sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 217 Kuwait sepsis diagnostics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Sepsis diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Sepsis diagnostics market dynamics
  • Fig. 15 Porter's Five Force Analysis
  • Fig. 16 Sepsis diagnostics market: PESTEL analysis
  • Fig. 17 Sepsis diagnostics market: Product outlook and key takeaways
  • Fig. 18 Sepsis diagnostics market: Product movement analysis
  • Fig. 19 Instrument sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Blood culture media sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Assay kits and reagents sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Sepsis diagnostics market: Technology outlook and key takeaways
  • Fig. 24 Sepsis diagnostics market: Technology movement analysis
  • Fig. 25 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Polymerase chain reaction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Syndromic panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Sepsis diagnostics market: Pathogen outlook and key takeaways
  • Fig. 35 Sepsis diagnostics market: Pathogen movement analysis
  • Fig. 36 Bacterial sepsis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Gram-positive bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Gram-negative bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Fungal sepsis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Viral sepsis and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sepsis diagnostics market: Testing outlook and key takeaways
  • Fig. 42 Sepsis diagnostics market: Testing movement analysis
  • Fig. 43 Laboratory testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Point-of-care testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Sepsis diagnostics market: Method outlook and key takeaways
  • Fig. 46 Sepsis diagnostics market: Method movement analysis
  • Fig. 47 Automated diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Conventional diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Sepsis diagnostics market: End user outlook and key takeaways
  • Fig. 50 Sepsis diagnostics market: End Use movement analysis
  • Fig. 51 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pathology & reference laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Research institutes and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Sepsis diagnostic market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 North America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 U.S. sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Canada sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Spain sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Italy sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Russia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Korea sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Singapore sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Rest of Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Mexico sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Argentina sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Rest of LATAM sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 South Africa sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Saudi Arabia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 UAE sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Kuwait sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Rest of MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Market participant categorization
  • Fig. 116 Company market positioning
  • Fig. 117 Sepsis diagnostics market share analysis, 2024
  • Fig. 118 Company heat map analysis
  • Fig. 119 Strategic framework